Detalles de la búsqueda
1.
Ibrutinib as first line therapy in chronic lymphocytic leukemia patients over 80 years old: A retrospective real-life multicenter Italian cohort.
Hematol Oncol
; 42(1): e3249, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38287529
2.
Lymphadenopathy as a predictor of progression during venetoclax treatment in chronic lymphocytic leukemia. A campus chronic lymphocytic leukemia study.
Hematol Oncol
; 41(5): 877-883, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37392141
3.
The role of Bruton's kinase inhibitors (BTKi) in accelerated Chronic Lymphocytic Leukemia (a-CLL): a case of successful response to acalabrutinib.
J Basic Clin Physiol Pharmacol
; 34(3): 401-404, 2023 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37040263
4.
Changing Trends in B-Cell Non-Hodgkin Lymphoma Treatment: The Role of Novel Monoclonal Antibodies in Clinical Practice.
Cancers (Basel)
; 15(22)2023 Nov 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38001657
5.
Spontaneous splenic rupture during induction therapy in acute myeloid leukemia: An unusual case.
Radiol Case Rep
; 16(11): 3406-3409, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34504634
6.
Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: a multicenter Italian study.
Blood Adv
; 6(13): 3875-3878, 2022 07 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35789375
7.
Osteonecrosis of the Jaws (ONJ) after Bisphosphonate Treatment in Patients with Multiple Myeloma: Decreasing ONJ Incidence after Adoption of Preventive Measures.
Dent J (Basel)
; 4(4)2016 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29563487
8.
Successful HLA haploidentical myeloablative stem cell transplantation for aggressive hepatosplenic alpha/beta (αß) T-cell lymphoma.
Leuk Res Rep
; 3(2): 90-3, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25429355
9.
Therapy of Hodgkin's lymphoma in clinical practice: A retrospective long-term follow-up analysis.
Oncol Lett
; 2(2): 289-295, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22866079
10.
Kinase domain mutations of BCR-ABL identified at diagnosis before imatinib-based therapy are associated with progression in patients with high Sokal risk chronic phase chronic myeloid leukemia.
Leuk Lymphoma
; 51(2): 275-8, 2010 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-20038234
11.
Clarithromycin potentiates tyrosine kinase inhibitor treatment in patients with resistant chronic myeloid leukemia.
Leuk Lymphoma
; 53(7): 1409-11, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22233113
12.
Adding low-dose gemtuzumab ozogamicin to fludarabine, Ara-C and idarubicin (MY-FLAI) may improve disease-free and overall survival in elderly patients with non-M3 acute myeloid leukaemia: results of a prospective, pilot, multi-centre trial and comparison with a historical cohort of patients.
Br J Haematol
; 138(2): 186-95, 2007 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-17593025
Resultados
1 -
12
de 12
1
Próxima >
>>